|
 |
|
Train more qualified toxicologic pathologists |
|
| |
Pros: |
| |
ACVP/STP Coalition |
| |
Cons: |
| |
Reduced funding, loss of training programs and fewer candidates |
|
| |
|
|
Establish parapathology training programs for tissue screening |
|
| |
Cons: |
| |
First attempted in the 70s @ the National Center for Toxicological Research (NCTR)
Serious being shown by big Pharma especially in Far East locations (e.g. Novartis, Lilly)
Significant performance concerns, head count issues, and GLP nightmares |
|
| |
|
|
Computerized Automation ("Smart Imaging") of Tissue Screening** |
|
| |
Pros: |
| |
Digital imaging, automated morphometrics, and telepathology
"Smart imaging" screening of Normal vs. Abnormal tissues
"Smarter imaging" with specific diagnostic discriminators identified and quantitated |
| |
Cons: |
| |
Development costs are steep, technology demanding and validation challenging |
|
| |
|
|
Other? |
|
| |
"Seat" will be lost and ultimately the discipline will be either pigeon-holed or replaced by an alternative science! |
|
| |
 |
| |
